Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer

Journal of Pharmaceutical and Biomedical Analysis

Volumn 131, Issue , 2016, Pages 256-262

  Carlier, Charlotte ^a   Laforce, Brecht ^b   Van Malderen, Stijn J M ^b   Gremonprez, Félix ^a   Tucoulou, Remi ^c   Villanova, Julie ^c   De Wever, Olivier ^a,b   Vincze, Laszlo ^b   Vanhaecke, Frank ^b   Ceelen, Wim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c EUROPEAN SYNCHROTRON RADIATION FACILITY   (France)

Author keywords

Hyperthermia; Intraperitoneal; LA ICP MS; Ovarian cancer; Pt distribution; Synchrotron radiation XRF

Indexed keywords

BROMINE; CALCIUM; CISPLATIN; IRON; MANGANESE; PHOSPHORUS; PLATINUM; SULFUR; ZINC; COPPER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG PENETRATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; LASER ABLATION INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; MASS SPECTROMETRY; MOUSE; NONHUMAN; OVARY CANCER; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; STROMA; SYNCHROTRON RADIATION; THERMOTHERAPY; TISSUE DISTRIBUTION; TUMOR CELL; TUMOR XENOGRAFT; X RAY FLUORESCENCE; ANIMAL; DISEASE MODEL; FEVER; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; OVARY TUMOR; PROCEDURES; SPECTROMETRY; ULTRASTRUCTURE; XENOGRAFT;

ANIMALS; CALCIUM; CISPLATIN; COPPER; DISEASE MODELS, ANIMAL; FEMALE; FEVER; HETEROGRAFTS; INJECTIONS, INTRAPERITONEAL; MASS SPECTROMETRY; MICE; OVARIAN NEOPLASMS; PHOSPHORUS; PLATINUM; SPECTROMETRY, X-RAY EMISSION; SULFUR; TISSUE DISTRIBUTION; ZINC;

EID: 84985961666     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2016.09.004     Document Type: Article

References (30)

1. [1] Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J.W., Comber, H., Forman, D., Bray, F., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer 49 (2013), 1374–1403.
2. [2] Colombo, N., Peiretti, M., Parma, G., Lapresa, M., Mancari, R., Carinelli, S., Sessa, C., Castiglione, M., ESMO Guidelines Working Group, Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 21 (2010), 23–30.
3. [3] de Bree, E., Helm, C.W., Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data. Expert Rev. Anticancer Ther. 12 (2012), 895–911.
4. [4] Huo, Y.R., Richards, A., Liauw, W., Morris, D.L., Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: a systematic review and meta-analysis. Eur. J. Surg. Oncol. 41 (2015), 1578–1589.
5. [5] Mas-Fuster, M.I., Ramon-Lopez, A., Nalda-Molina, R., Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view. Cancer Chemother. Pharmacol. 72 (2013), 273–274.
6. [6] Gil, S., Carmona, A., Martinez-Criado, G., Leon, A., Prezado, Y., Sabes, M., Analysis of platinum and trace metals in treated glioma rat cells by X-ray fluorescence emission. Biol. Trace Elem. Res. 163 (2015), 177–183.
7. [7] Sakurai, H., Okamoto, M., Hasegawa, M., Satoh, T., Oikawa, M., Kamiya, T., Arakawa, K., Nakano, T., Direct visualization and quantification of the anticancer agent cis-diamminedichloro-platinum(II), in human lung cancer cells using in-air microparticle-induced X-ray emission analysis. Cancer Sci. 99 (2008), 901–904.
8. [8] Seo, B.R., Delnero, P., Fischbach, C., In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv. Drug Deliv. 69–70 (2014), 205–216.
9. [9] Workman, P., Aboagye, E.O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D.J., Double, J.A., Everitt, J., Farningham, D.A., Glennie, M.J., Kelland, L.R., Robinson, V., Stratford, I.J., Tozer, G.M., Watson, S., Wedge, S.R., Eccles, S.A., An ad hoc committee of the National Cancer Research Institute, Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102 (2010), 1555–1577.
10. [10] Martínez-Criado, V.J., Villanova, G.J., Tucoulou, R., Salomon, D., Suuronen, J.P., Labouré, S., Guilloud, C., Valls, V., Barrett, R., Gagliardini, E., Dabin, Y., Baker, R., Bohic, C., Cohen, C., Morse, J., ID16B: a hard X-ray nanoprobe beamline at the ESRF for nano-analysis. J. Synchrotron Radiat. 23 (2016), 344–352.
11. [11] Vekemans, B., Janssens, K., Vincze, L., Aerts, A., Adams, F., Hertogen, J., Automated segmentation of mu-XRF image sets. X-Ray Spectrom. 26 (1997), 333–346.
12. [12] Laforce, B., Carlier, C., Vekemans, B., Villanova, J., Tucoulou, R., Ceelen, W., Vincze, L., Assessment of ovarian cancer tumors treated with intraperitoneal cisplatin therapy by nanoscopic X-ray fluorescence imaging. Sci. Rep., 6, 2016, 29999.
13. [13] Schoonjans, T., Sole, V.A., Vincze, L., del Rio, M.S., Appel, K., Ferrero, C., A general Monte Carlo simulation of energy-dispersive X-ray fluorescence spectrometers—part 6. Quantification through iterative simulations. Spectrochim. Acta B 82 (2013), 36–41.
14. [14] Yotsuyanagi, T., Usami, M., Noda, Y., Nagata, M., Computational consideration of cisplatin hydrolysis and acid dissociation in aqueous media: effect of total drug concentrations. Int. J. Pharm. 246 (2002), 95–104.
15. [15] Asimakopoulou, A.P., Theocharis, A.D., Tzanakakis, G.N., Karamanos, N.K., The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In Vivo 22 (2008), 385–389.
16. [16] http://www.uniprot.org/uniprot/P02458.
17. [17] Resende, R.R., Andrade, L.M., Oliveira, A.G., Guimaraes, E.S., Guatimosim, S., Leite, M.F., Nucleoplasmic calcium signaling and cell proliferation: calcium signaling in the nucleus. Cell Commun. Signal., 11, 2013, 14.
18. [18] Santella, L., Carafoli, E., Calcium signaling in the cell nucleus. FASEB J. 11:13 (1997), 1091–1109.
19. [19] Los, G., Sminia, P., Wondergem, J., Mutsaers, P.H., Havemen, J., ten Bokkel Huinink, D., Smals, O., Gonzalez-Gonzalez, D., McVie, J.G., Optimisation of intraperitoneal cisplatin therapy with regional hyperthermia in rats. Eur. J. Cancer 27 (1991), 472–477.
20. [20] Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerner, T., Felix, R., Riess, H., The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43 (2002), 33–56.
21. [21] Sminia, P., Los, G., Hendriks, J.J., van Vugt, M.J., Haveman, J., Gonzalez Gonzalez, D., The influence of hyperthermia on the uptake of cisplatin in the rat cervical spinal cord. Eur. J. Cancer 28A:6–7 (1992), 1139–1143.
22. [22] Los, G., van Vugt, M.J., den Engelse, L., Pinedo, H.M., Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA. Biochem. Pharmacol. 46 (1993), 1229–1237.
23. [23] Papahadjopoulos, D., Nir, S., Oki, S., Permeability properties of phospholipid membranes: effect of cholesterol and temperature. Biochim. Biophys. Acta 266 (1972), 561–583.
24. [24] El-Kareh, A.W., Secomb, T.W., A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia 6 (2004), 117–127.
25. [25] Tang, W.J., Liu, Y.W., Zhang, H., Wang, C.X., New approximate formula for Arrhenius temperature integral. Thermochim. Acta 408 (2003), 39–43.
26. [26] van Driel, W.J., Lok, C.A., Verwaal, V., Sonke, G.S., The role of hyperthermic intraperitoneal intraoperative chemotherapy in ovarian cancer. Curr. Treat. Options Oncol., 16, 2015, 14.
27. [27] Simon-Gracia, L., Hunt, H., Scodeller, P.D., Gaitzsch, J., Braun, G.B., Willmore, A.M., Ruoslahti, E., Battaglia, G., Teesalu, T., Paclitaxel-loaded polymersomes for enhanced intraperitoneal chemotherapy. Mol. Cancer Ther. 15 (2016), 670–679.
28. [28] Theiner, S., Kornauth, C., Varbanov, H.P., Galanski, M., Van Schoonhoven, S., Heffeter, P., Berger, W., Egger, A.E., Keppler, B.K., Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents. Metallomics 7 (2015), 1256–1264.
29. [29] Chen, H.H., Kuo, M.T., Role of glutathione in the regulation of cisplatin resistance in cancer chemotherapy. Met. Based Drugs, 2010, 2010, 430939.
30. [30] Ortega, R., Deves, G., Carmona, A., Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J. R. Soc. Interface 6 (2009), S649–S658.